[The efferent therapy of Raynaud's phenomenon].
The method of discrete plasmacytapheresis was applied for the treatment of 8 patients with primary and 18 with secondary Raynaud's phenomenon. The incorporation of this method in the therapeutic complex have promoted the achievement of clinical improvement in the whole of the patients with primary and in 13 with secondary Raynaud's phenomenon. Remission lasted from 1.5 months till 4.5 years. Positive effect is caused by the improvement of blood rheological properties on the hemodilution background, the excretion of pathological substances from blood flow.
Loba
M M
MM
Orel
Iu H
IuH
D000293:Adolescent; D000328:Adult; D002908:Chronic Disease; D003131:Combined Modality Therapy; D016238:Cytapheresis / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male; D010956:Plasmapheresis / Q000379:methods*; D011928:Raynaud Disease / Q000097:blood / Q000628:therapy*; D012074:Remission Induction